Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease

Macrophage activation syndrome is the most frequent life-threatening complication of adult-onset Still’s disease. This is a nearly fatal case of a young patient, which has been refractory to corticosteroids, anakinra, tocilizumab, cyclosporine A, and etoposide, but eventually responded miraculously...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Ofer, Apel, Arie, Alhdor, Hossam, Mizrachi, Avraham, Agmon-Levin, Nancy, Koren-Michowitz, Maya, Amit-Vazina, Mirit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mesut Onat 2022
Materias:
Case-based Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089131/
https://www.ncbi.nlm.nih.gov/pubmed/35943464
http://dx.doi.org/10.5152/eurjrheum.2022.21064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089131/
https://www.ncbi.nlm.nih.gov/pubmed/35943464
http://dx.doi.org/10.5152/eurjrheum.2022.21064

Ejemplares similares